Primary Prevention of Cardiovascular Disease and Type 2 Diabetes Mellitus Using Mobile Health Technology: Systematic Review of the Literature.
cardiovascular diseases
diabetes mellitus, type 2
mobile health
primary prevention
systematic review
telemedicine
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
29 10 2020
29 10 2020
Historique:
received:
06
06
2020
accepted:
02
09
2020
revised:
10
08
2020
entrez:
29
10
2020
pubmed:
30
10
2020
medline:
30
1
2021
Statut:
epublish
Résumé
Digital technology is an opportunity for public health interventions to reach a large part of the population. This systematic literature review aimed to assess the effectiveness of mobile health-based interventions in reducing the risk of cardiovascular disease and type 2 diabetes mellitus. We conducted the systematic search in 7 electronic databases using a predefined search strategy. We included articles published between inception of the databases and March 2019 if they reported on the effectiveness of an intervention for prevention of cardiovascular disease or type 2 diabetes via mobile technology. One researcher performed the search, study selection, data extraction, and methodological quality assessment. The steps were validated by the other members of the research team. The search yielded 941 articles for cardiovascular disease, of which 3 met the inclusion criteria, and 732 for type 2 diabetes, of which 6 met the inclusion criteria. The methodological quality of the studies was low, with the main issue being nonblinding of participants. Of the selected studies, 4 used SMS text messaging, 1 used WhatsApp, and the remaining ones used specific smartphone apps. Weight loss and reduction in BMI were the most reported successful outcomes (reported in 4 studies). Evidence on the effectiveness of mobile health-based interventions in reducing the risk for cardiovascular disease and type 2 diabetes is low due to the quality of the studies and the small effects that were measured. This highlights the need for further high-quality research to investigate the potential of mobile health interventions. International Prospective Register of Systematic Reviews (PROSPERO) CRD42019135405; https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=135405.
Sections du résumé
BACKGROUND
Digital technology is an opportunity for public health interventions to reach a large part of the population.
OBJECTIVE
This systematic literature review aimed to assess the effectiveness of mobile health-based interventions in reducing the risk of cardiovascular disease and type 2 diabetes mellitus.
METHODS
We conducted the systematic search in 7 electronic databases using a predefined search strategy. We included articles published between inception of the databases and March 2019 if they reported on the effectiveness of an intervention for prevention of cardiovascular disease or type 2 diabetes via mobile technology. One researcher performed the search, study selection, data extraction, and methodological quality assessment. The steps were validated by the other members of the research team.
RESULTS
The search yielded 941 articles for cardiovascular disease, of which 3 met the inclusion criteria, and 732 for type 2 diabetes, of which 6 met the inclusion criteria. The methodological quality of the studies was low, with the main issue being nonblinding of participants. Of the selected studies, 4 used SMS text messaging, 1 used WhatsApp, and the remaining ones used specific smartphone apps. Weight loss and reduction in BMI were the most reported successful outcomes (reported in 4 studies).
CONCLUSIONS
Evidence on the effectiveness of mobile health-based interventions in reducing the risk for cardiovascular disease and type 2 diabetes is low due to the quality of the studies and the small effects that were measured. This highlights the need for further high-quality research to investigate the potential of mobile health interventions.
TRIAL REGISTRATION
International Prospective Register of Systematic Reviews (PROSPERO) CRD42019135405; https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=135405.
Identifiants
pubmed: 33118936
pii: v22i10e21159
doi: 10.2196/21159
pmc: PMC7661239
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e21159Informations de copyright
©Vera Helen Buss, Stuart Leesong, Margo Barr, Marlien Varnfield, Mark Harris. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 29.10.2020.
Références
Contemp Clin Trials Commun. 2018 Sep 20;12:76-84
pubmed: 30294699
Am J Prev Med. 2017 Jul;53(1):e19-e30
pubmed: 28258777
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
JMIR Mhealth Uhealth. 2018 Jul 23;6(7):e10723
pubmed: 30037787
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
BMJ. 2005 Nov 5;331(7524):1064-5
pubmed: 16230312
J Sports Med Phys Fitness. 2017 Jan-Feb;57(1-2):90-102
pubmed: 26364690
J Med Internet Res. 2018 May 04;20(5):e162
pubmed: 29728346
J Med Internet Res. 2015 Oct 23;17(10):e240
pubmed: 26499966
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Arch Intern Med. 2012 Jun 11;172(11):837-44
pubmed: 22688992
J Diabetes Sci Technol. 2018 Jul;12(4):831-838
pubmed: 29584454
Arch Intern Med. 2007 May 28;167(10):1068-74
pubmed: 17533210
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
Prev Med Rep. 2018 Nov 30;13:126-131
pubmed: 30568871
Lancet Diabetes Endocrinol. 2013 Nov;1(3):191-8
pubmed: 24622367
Diabetes Care. 2016 Aug;39(8):1364-70
pubmed: 26861922
Lancet Diabetes Endocrinol. 2016 Jan;4(1):52-63
pubmed: 26653067
PLoS One. 2018 Jan 5;13(1):e0189801
pubmed: 29304148
J Behav Med. 2017 Feb;40(1):194-202
pubmed: 27785652
Cochrane Database Syst Rev. 2016 Apr 10;4:CD006611
pubmed: 27060875
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
BMC Med. 2019 Jun 12;17(1):108
pubmed: 31186007
CMAJ. 2018 Apr 3;190(13):E378-E379
pubmed: 29615420
Eur J Clin Nutr. 2018 Jan;72(1):57-65
pubmed: 29091078
Eur J Prev Cardiol. 2018 Mar;25(5):505-521
pubmed: 29313363
Transl Behav Med. 2011 Mar;1(1):53-71
pubmed: 21796270
Am J Prev Med. 2015 Aug;49(2):223-37
pubmed: 26033349
Prev Med. 2015 Dec;81:16-41
pubmed: 26190368
JMIR Mhealth Uhealth. 2019 Jan 15;7(1):e12297
pubmed: 30664494